Used as a key intermediate in the synthesis of fluoroquinolone antibiotics, particularly in the development of advanced antimicrobial agents targeting resistant bacterial strains. Its structure enables enhanced penetration into bacterial cells and improved binding to DNA gyrase and topoisomerase IV, critical enzymes for bacterial DNA replication. This compound contributes to the efficacy of next-generation antibiotics with broad-spectrum activity, especially against Gram-negative pathogens. It is also employed in pharmaceutical research to optimize drug potency, pharmacokinetics, and resistance profiles.